Nasdaq:US$17.93 (+1.56) | HKEX:HK$28.00 (+2.82) | AIM:£2.59 (+0.2)
Search Result
Previous Article   |   Next Article
Announcements & Press Releases, Oncology / Immunology | 13 Jul 2009

Phase II Crohn’s Disease Trial for HMPL-004 Delivers Encouraging Results

1 items
a090713